about
Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, MadagascarEosinophil granule proteins ECP and EPX as markers for a potential early-stage inflammatory lesion in female genital schistosomiasis (FGS).Case-control study of the etiology of infant diarrheal disease in 14 districts in Madagascar.Seroprevalence of malaria in inhabitants of the urban zone of Antananarivo, Madagascar.Gynecological manifestations, histopathological findings, and schistosoma-specific polymerase chain reaction results among women with Schistosoma haematobium infection: a cross-sectional study in Madagascar.Coexistence of urogenital schistosomiasis and sexually transmitted infection in women and men living in an area where Schistosoma haematobium is endemic.[Persistence of an endemic circulation of the West Nile virus in Madagascar]Rotavirus genotypes in children in the community with diarrhea in Madagascar.Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes.Antimicrobial resistance in pathogens causing nosocomial infections in surgery and intensive care units of two hospitals in Antananarivo, Madagascar.Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extended-spectrum beta-lactamases.Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity.Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.[Effect of praziquantel on the uro-nephrologic complications of urinary bilharziasis]Clinical findings in female genital schistosomiasis in Madagascar.[Ultrasonographic evaluation of Schistosoma mansoni morbidity: comparison of Cairo/WHO and Managil-Hannover classifications][Use of ultrasonography in Schistosoma mansoni infections: from the past to the present and future perspectives]Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters.
P50
Q27485718-E41003F8-A318-4907-A146-CE948365695EQ33916102-76B81B61-D650-4858-8874-66848E29E284Q34427148-D88680FD-D361-4018-8D4D-4328B810B63FQ35157517-4CC4808A-B69B-4658-9E18-0F56B4DFFED4Q35786359-9DF69A64-B3DB-4DC9-B1F1-8DCC63D6B51AQ37856887-023236F3-5FE7-4DDD-9F83-E26AFE9CE043Q40516118-874195DF-DD32-4945-933D-8FB8A73A1037Q41396305-2958365A-27D4-49F7-A57C-FBE775FDA5ACQ41432945-A3B23AEF-2696-4E36-B202-7280C1E83C85Q41434942-7B4BC899-C07E-440D-A2C3-0308DA88BBC3Q41439672-C2A53D2E-3371-48F5-99A1-2E724508B2F7Q41474862-242F9E94-6F91-4BDF-9DF5-E80B6DFC0B86Q41484277-EAFE76B4-1AB9-4661-BD92-F8003A28F112Q41484367-B35E7BCD-CC48-4D45-A5C6-7DFFE1A7CFFBQ41485814-9EEE0968-4CD6-4B85-8CF9-419DCFB0B88BQ41492034-643047B7-807F-40A4-86FF-C4375383D3E0Q41492044-70159CDF-C39B-432B-83B6-236491E824E8Q43953235-5B4A500B-72E3-45F3-BFDE-082956E94043
P50
description
researcher, ORCID id # 0000-0001-7831-7057
@en
wetenschapper
@nl
name
Charles E Ramarokoto
@ast
Charles E Ramarokoto
@en
Charles E Ramarokoto
@es
Charles E Ramarokoto
@nl
type
label
Charles E Ramarokoto
@ast
Charles E Ramarokoto
@en
Charles E Ramarokoto
@es
Charles E Ramarokoto
@nl
prefLabel
Charles E Ramarokoto
@ast
Charles E Ramarokoto
@en
Charles E Ramarokoto
@es
Charles E Ramarokoto
@nl
P106
P31
P496
0000-0001-7831-7057